What if the mosquito net
wasn’t completely closed?
Learn more about helping to protect travellers from Japanese Encephalitis
Help Reduce Risk for Your Patients by Knowing the Facts
CLICK TO EXPAND
KEY FACTS ABOUT JAPANESE ENCEPHALITIS
Japanese Encephalitis is not just in Japan
The Japanese Encephalitis virus is endemic to 24 countries across Asia and Southeast Asia, as well as parts of the western Pacific.4
JE is the most common vaccine
-preventable encephalitis in Asia
JE is the leading cause of viral-induced neurologic sequelae.4,6
There is no specific
treatment for JE
The only protection against JE is prevention6,7†
† IXIARO® is not indicated to prevent consequences of JE once it develops.
One vaccine can help
protect them
Consider IXIARO® for your patients aged
≥ 2 months for the prevention of JE1
What is Ixiaro?®
What can you do to help protect
patients against JE?
Learn more about risk reduction strategies
and vaccination for travellers at risk
Help prevent JE
IXIARO® is indicated for active immunization against Japanese Encephalitis for persons 2 months of age and older.
IXIARO® should be considered for use in individuals at risk of exposure through travel or in the course of their occupation. As with any other vaccine, vaccination with IXIARO® may not result in protection in all cases. IXIARO® will not protect against encephalitis caused by other micro-organisms.
Check the Safety Information section for additional information discussing
- Contraindications: Hypersensitivity to this vaccine or to any ingredient in the formulation or component of the container; do not give the second dose to individuals who show hypersensitivity reactions after the first dose; postpone vaccination with IXIARO® in persons with acute severe febrile conditions
- Most serious warnings and precautions regarding treating rare cases of anaphylactic reactions following the administration of the vaccine; administration of IXIARO® and bleeding disorders
- Other relevant warnings and precautions regarding pregnant and nursing women, geriatrics (≥65 years of age) and immunosuppressed individuals
- Conditions of clinical use, adverse reactions, drug interactions and dosing instructions
Please see IXIARO® Product Monograph for complete prescribing information.

VALNEVA Canada Inc.
600-3535, Saint-Charles Blvd.
Kirkland (Montreal), Quebec
H9H 5B9